152 related articles for article (PubMed ID: 28060709)
21. Development and testing of particulate formulations for the nasal delivery of antibodies.
Kaye RS; Purewal TS; Alpar OH
J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
[TBL] [Abstract][Full Text] [Related]
22. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation.
Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409
[TBL] [Abstract][Full Text] [Related]
23. Effect of absorption promoters in intranasal administration of human fibroblast interferon as a powder dosage form in rabbits.
Igawa T; Maitani Y; Machida Y; Nagai T
Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):418-21. PubMed ID: 2743486
[TBL] [Abstract][Full Text] [Related]
24. Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems.
Ikechukwu Ugwoke M; Kaufmann G; Verbeke N; Kinget R
Int J Pharm; 2000 Jul; 202(1-2):125-31. PubMed ID: 10915935
[TBL] [Abstract][Full Text] [Related]
25. Dry powder nasal vaccines as an alternative to needle-based delivery.
Hickey AJ; Garmise RJ
Crit Rev Ther Drug Carrier Syst; 2009; 26(1):1-27. PubMed ID: 19496746
[TBL] [Abstract][Full Text] [Related]
26. Zolpidem Mucoadhesive Formulations for Intranasal Delivery: Characterization, In Vitro Permeability, Pharmacokinetics, and Nasal Ciliotoxicity in Rats.
Wang Y; Li M; Qian S; Zhang Q; Zhou L; Zuo Z; Lee B; Toh M; Ho T
J Pharm Sci; 2016 Sep; 105(9):2840-2847. PubMed ID: 27189774
[TBL] [Abstract][Full Text] [Related]
27. Characterization and in vitro evaluation of freeze-dried microparticles composed of granisetron-cyclodextrin complex and carboxymethylcellulose for intranasal delivery.
Cho HJ; Balakrishnan P; Shim WS; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2010 Nov; 400(1-2):59-65. PubMed ID: 20801202
[TBL] [Abstract][Full Text] [Related]
28. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
Schipper NG; Romeijn SG; Verhoef JC; Merkus FW
Pharm Res; 1993 May; 10(5):682-6. PubMed ID: 8321831
[TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of nicotine lyophilised nasal insert in sheep.
McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN
Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221
[TBL] [Abstract][Full Text] [Related]
30. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
[TBL] [Abstract][Full Text] [Related]
31. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Charlton ST; Davis SS; Illum L
J Control Release; 2007 Apr; 118(2):225-34. PubMed ID: 17261340
[TBL] [Abstract][Full Text] [Related]
33. Optimising nasal powder drug delivery - Characterisation of the effect of excipients on drug absorption.
Trenkel M; Scherließ R
Int J Pharm; 2023 Feb; 633():122630. PubMed ID: 36690127
[TBL] [Abstract][Full Text] [Related]
34. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
35. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
[TBL] [Abstract][Full Text] [Related]
36. [Preparation of freeze-dried powder of recombinate hirudin-2 nanoparticle for nasal delivery and permeability through nasal membrane in vitro].
Chen MX; Zhang JB; Yu JP; Ye J; Wei BH; Zhang YJ
Zhong Yao Cai; 2013 Jun; 36(6):999-1002. PubMed ID: 24380289
[TBL] [Abstract][Full Text] [Related]
37. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
38. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
Pozzoli M; Traini D; Young PM; Sukkar MB; Sonvico F
Drug Dev Ind Pharm; 2017 Sep; 43(9):1510-1518. PubMed ID: 28425305
[TBL] [Abstract][Full Text] [Related]
39. Nasal absorption of propranolol from different dosage forms by rats and dogs.
Hussain A; Hirai S; Bawarshi R
J Pharm Sci; 1980 Dec; 69(12):1411-3. PubMed ID: 7463327
[TBL] [Abstract][Full Text] [Related]
40. Next generation of buccadhesive excipient: Preactivated carboxymethyl cellulose.
Laffleur F; Bacher L; Vanicek S; Menzel C; Muhammad I
Int J Pharm; 2016 Mar; 500(1-2):120-7. PubMed ID: 26773600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
